Clinical Trial Update: Study of Recombinant Human-Mouse Chimeric Anti-CD20 Monoclonal Antibody to Treat Non-hodgkin's Lymphoma [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating a recombinant human-mouse chimeric anti-CD20 monoclonal antibody for diffuse large B-cell lymphoma (a type of non-Hodgkin lymphoma) h…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Large B-cell Lymphoma
• Non-hodgkin Lymphoma

Drugs mentioned

• Recombinant Human-Mouse Chimeric Anti-CD20 Monoclonal Antibody

Snippet

Sponsor: Shanghai CP Guojian Pharmaceutical Co., Ltd. | Conditions: Diffuse Large B Cell Lymphoma | Phase 3 | Status: COMPLETED